Laurel Wealth Advisors (California)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.1M | Sell |
|
|||||
|
2022
Q3 | $1.08M | Buy |
|
|||||
|
2022
Q2 | $1.17M | Sell |
|
|||||
|
2022
Q1 | $1.14M | Sell |
|
|||||
|
2021
Q4 | $996K | Buy |
|
|||||
|
2021
Q3 | $649K | Sell |
|
|||||
|
2021
Q2 | $745K | Buy |
|
|||||
|
2021
Q1 | $702K | Sell |
|
|||||
|
2020
Q4 | $730K | Sell |
|
|||||
|
2020
Q3 | $712K | Sell |
|
|||||
|
2020
Q2 | $696K | Sell |
|
|||||
|
2020
Q1 | $662K | Sell |
|
|||||
|
2019
Q4 | $765K | Sell |
|
|||||
|
2019
Q3 | $887K | Buy |
|
|||||
|
2019
Q2 | $419K | Buy |
|
|||||
|
2019
Q1 | $372K | Buy |
|
|||||
|
2018
Q4 | $396K | Sell |
|
|||||
|
2018
Q3 | $525K | Buy |
|
|||||
|
2018
Q2 | $453K | Buy |
|
|||||
|
2018
Q1 | $503K | Buy |
|
|||||
|
2017
Q4 | $441K | Buy |
|
|||||
|
2017
Q3 | $402K | Buy |
|
|||||
|
2017
Q2 | $351K | Buy |
|
|||||
|
2017
Q1 | $320K | Sell |
|
|||||
|
2016
Q4 | $383K | Sell |
|
|||||
|
2016
Q3 | $421K | Buy |
|
|||||
|
2016
Q2 | $558K | Buy |
|
|||||
|
2016
Q1 | $420K | Sell |
|
|||||
|
2015
Q4 | $515K | Buy |
|